Fundraising FoxSpring Bank Pharmaceuticals
Milford, US · Delaware corporation
Find your way into Spring Bank Pharmaceuticals
Sign up to see every warm intro you have to Spring Bank Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Spring Bank Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
RP
Radhakrishnan Parameswaran IyerFounder
DJ
Douglas John JensenExecutive
MF
Michael Francis CroninExecutive
DM
Donald Moore MitchellExecutive
NA
Nezam AfdhalExecutive
GB
Gregg BeloffExecutive
Board
DA
David ArkowitzBoard director
JE
Jonathan Ellsworth BatesBoard director
GM
Guy MacdonaldBoard director
Reported raises · per SEC filings
Form D private placements$43M disclosed across 3 rounds · 2013–2016
▶$15MraisedNov 2016 · 24 investors · BiotechnologyRule 506(b)
▶$15MraisedNov 2016 · 24 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan BatesDirector
- R.P. Kris IyerDirector
- David ArkowitzDirector
- Nezam AfdhalExecutive Officer
- Jonathan FreveExecutive Officer
- Martin DriscollExecutive Officer, Director
- Kurt M. EichlerDirector
- Offering amount
- $15M
- Amount sold
- $15M
- Sales commissions
- $900K
- Placement agents
- William Blair & Company, L.L.C.
- First sale
- Nov 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$21.6MraisedFeb 2015 · 72 investors · BiotechnologyRule 506(b)
▶$21.6MraisedFeb 2015 · 72 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David ArkowitzDirector
- Radhakrishnan Parameswaran IyerExecutive Officer, Director
- Jonathan Ellsworth BatesDirector
- Guy MacdonaldDirector
- Douglas John JensenExecutive Officer, Director
- Offering amount
- $21.6M
- Amount sold
- $21.6M
- Sales commissions
- $1.6M
- Placement agents
- Gilford Securities
- First sale
- Dec 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.3MraisedFeb 2014 · 36 investors · BiotechnologyRule 506(b)
▶$6.3MraisedFeb 2014 · 36 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael Francis CroninExecutive Officer
- Jonathan Ellsworth BatesDirector
- Guy MacdonaldDirector
- Radhakrishnan Parameswaran IyerExecutive Officer, Director
- David ArkowitzDirector
- Douglas John JensenExecutive Officer, Director
- Donald Moore MitchellExecutive Officer
- Nezam AfdhalExecutive Officer
- Gregg BeloffExecutive Officer
- Offering amount
- $6.3M
- Amount sold
- $6.3M
- First sale
- Oct 2013
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Spring Bank Pharmaceuticals?
- Spring Bank Pharmaceuticals was founded by Radhakrishnan Parameswaran Iyer.
- How much funding has Spring Bank Pharmaceuticals raised?
- Spring Bank Pharmaceuticals has disclosed $43M raised across 3 rounds.
- Where is Spring Bank Pharmaceuticals headquartered?
- Spring Bank Pharmaceuticals is headquartered in Milford, US.